Hasil Pencarian - U Holtick

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH HEMATOLOGICAL MALIGNANCIES

    S235: A TWO-PART, SINGLE- AND TWO-ARM RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE S1P RECEPTOR MODULATOR KRP203 IN SUBJECTS WITH H... oleh S. dertschnig, J. finke, D. heim, U. schanz, E. holler, U. holtick, G. socié, T. teshima, C. bucher, J. passweg

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation

    Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation oleh T. Richardson, D. Schütte, K. Feyer, L. Grass, M. Hallek, C. Scheid, F. Simon, T. Braun, M. Fürstenau, P. Gödel, U. Holtick

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation

    P10.01 Nutritional and immunometabolic measures for risk assessment in allogeneic hematopoietic stem cell transplantation oleh S Theurich, M von Bergwelt-Baildon, M Funk, K Althoff, S Leitzke, U Holtick, C Scheid, D Cordas dos Santos, S Oganesian, H Thurisch

    Diterbitkan 2024-03-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT

    P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT oleh P. Borchmann, A. Lohneis, P. Gödel, H. Balke-Want, C. Schmid, F. Ayuk, S. Holtkamp, L. Hanssens, G. Zadoyan, B. Friedrichs, M. Assenmacher, I. Bürger, D. Schneider, T. Overstijns, C. Scheid, U. Holtick, S. Miltenyi, M. Hallek

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY

    P1448: LONG-TERM SURVIVORS AFTER FAILURE OF CAR-T CELL THERAPY FOR R/R LARGE B-CELL LYMPHOMA (LBCL): A GLA/DRST STUDY oleh P. Derigs, W. Bethge, U. Holtick, B. von Tresckow, F. Ayuk, O. Penack, V. Vucinic, M. von Bonin, C. Baldus, D. Mougiakakos, G. Wulf, U. Schnetzke, M. Stelljes, S. Thomas, R. Schroers, N. Kroeger, P. Dreger

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CH... oleh V. Bücklein, A. Perez, G. Iacoboni, K. Rejeski, U. Holtick, O. Penack, S. Kharboutli, V. Blumenberg, J. Ackermann, L. Frölich, G. Johnson, K. Patel, B. Arciola, C. Schmidt, O. Albanyan, P. Gödel, E. Hoster, L. Bullinger, A. Mackensen, F. Locke, M. von Bergwelt, P. Barba, M. D. Jain, M. Subklewe

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: